Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
It’s day 4 of SABCS 2023! Today, we’ll be hearing about recent advances in triple negative breast cancer ❗️🔬
http://VJOncology.com will have all the updates from SABCS shortly! 💻
#SABCS23 #BreastCancer #BCsm @SABCSSanAntonio @aacr
📽️@VJOncology are really enjoying catching up on all of the great research going on in #breastcancer at #SABCS23
See our latest coverage here 👉https://www.vjoncology.com/event/sabcs-2023/
🎥Charles Parker, MBBS, of @uclcancer explores the role of digital pathology and AI-derived models in guiding treatment decisions for high-risk prostate cancer:
#ESMO23 #PCSM #UroOnc #UroSoMe
Multimodal artificial intelligence models in prostate cancer
Charles Parker, MBBS, UCL Cancer Institute, London, UK, discusses the development of digital pathology-based multimodal ...
It was a pleasure speaking with @VKaklamani of @UTHealthSA and co-director of #SABCS23 yesterday who discussed key take-home messages from the meeting
@SABCSSanAntonio @AACR #BreastCancer #BCsm @OncoAlert
It’s day 2 of SABCS 2023! On the agenda today is a state-of-the-art immunotherapy showcase session 💊❗️
Keep up to date with everything SABCS related on http://VJOncology.com 💻
#SABCS23 #BreastCancer #BCsm @SABCSSanAntonio @aacr #ImmunoOnc
Immunotherapy offers patients and physicians a wider plethora of options and is becoming increasingly prevalent in the GI cancer space.
Speaking to leading experts, we got the latest on this rapidly growing field.
The inaugural OncoAlert Colloquium starting on December 14, 2020 brought together experts to present the biggest finding and changes to clinical practice during 2020, check out the presentations by clicking the link below!